Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice

Ítems similars

• Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c Mice
  per: Radu, Gertrud U., et al.
  Publicat: (2010)
• Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice
  per: Rey, Gertrud U., et al.
  Publicat: (2013)
• Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model
  per: Caidi, Hayat, et al.
  Publicat: (2018)
• Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab′)(2) components mediates reduced pulmonary inflammation in mice
  per: Miao, Congrong, et al.
  Publicat: (2009)
• An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice
  per: Boyoglu-Barnum, Seyhan, et al.
  Publicat: (2015)